Posted by Michael Wonder on 02 Nov 2016
Sanders takes aim at insulin makers in latest price attack
1 November 2016 - Eli Lilly shares briefly drop after tweet by senator.
Makers of insulin became the latest target for Senator Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices.
Shares of Eli Lilly & Co. fell after the senator, an independent lawmaker from Vermont, criticised the company and Novo Nordisk over the price of insulin. Along with France’s Sanofi, they are among the world’s largest producers of the drugs, which are used by millions of diabetics.
“People are dying or getting sicker because they can’t afford their insulin,” Sanders tweeted Tuesday. “Just so Eli Lilly and Novo Nordisk can make outrageous profits.”
